260 likes | 486 Views
. 213000 new case of lung cancer , 5 years survival just only 15%\Past few decade is staticBecause 50% case was advance cancer when they come to DrIn the past decade increase interest in the role of low dose spiral CTCXR missed 70-80% of lung cancer detect by the CT. . CT screening trials have r
E N D
1. I-ELCAP
2. 213000 new case of lung cancer , 5 years survival just only 15%\
Past few decade is static
Because 50% case was advance cancer when they come to Dr
In the past decade increase interest in the role of low dose spiral CT
CXR missed 70-80% of lung cancer detect by the CT
3. CT screening trials have report higher rate of early lung cancer 70-80%(stage Ia)
Average size of CT :1.5cm
Average size of CXR : 3cm
SEER new diagnosed lung cancer stage I ONLY 25%
SURVIVAL < 2cM IS BETTER THAN > 2-3CM
4. Can increase 10x of operation
But not all screen detect cancer are curable some were stage III at the time of diagnosis
Interval lung cancer (cancer that develop between annual screening CT scan) rapid growth and frequently small cell lung cancer
Most controversial is cost effect
5. www.I-ELCAP.org From 1993 ELCAP..I-ELCAP
CT screen for lung cancer
15% has positive result
6% has repeat positive result
6. Definition of Positive result? At least I solid pr part solid noncalcified nodule 5mm or more in diameter
Or at least one nonsolid noncalcified nodule 8mm or more in diameter
If there is noncalcified nodule but too small ,…semipositive ..calling for repeat one year later.
7. Repeat screening; positive? Growth in size
Growth in consistency
Growth in soilid componant in semi-solid or previois non solid nodule
8. The I-ELCAP regimen provides recommendation for the work up Follow their protocol 90% of biopsy result in malignancy
Recommendation turned out to be quite successful
None of biopsy without recommendation was cancer
9. 85% of the screen–diagnosis is stage I
Also found the tumor size in this stage I cancer is more smaller
The % of stage I lung cancer were much higher than SEER data(surveillance,epidermiology, and end result )program.
Long term F/U10 years survival rate regardless of stage and tx was 80%
Clinical stage I 10 years survival was 92 %
10. Pathology of lung adenocarcinoma and CT screening specimens Major subtype of adenocarcinoma
2004 WHO major subtype : mixed subtype,acinar, papillary, BAC (mucinous nonmucinous, mix)
Some subtype is more invasive and some are sensitive to iressa
EGFR and K ras mutation
CT screening 94% was adenocarcinoma
11. Molecular pathways to lung adenocarcinoma Adenocarcinoam is more and or esp in women and young patient and nonsmoker
Microarray expression studies demonstrate that gene expression is very different in smoker and nonsmoker
Smoking activation to RAS signaling
Non-smoking associated activation of EGFR signaling
12. Limited resection for small peripheral carcinoma Systematic nodal dissection could improved stage-specific survival and may improved overall survival. So lobectomy and SND still is standard choice
<1cm tumor has 10 % node metastasis
2cm tumor has 20-40% has node metastasis and 2/3 is N2
13. But due to CT screening: the tumor is more smaller so limited resection could we try in select case?
GGA( Ground glass attenuation )>50% of the total tumor size have a similary good prognosis (Noguchi classification)sublobar resection may be appropriate in selected case, but can cure? Wary .
14. Pre-invasive lesion (patho) 1999: squamous dysplasia and carcnoma in situs
2004: atypical adenomatous hyperplasia, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia
May be multicentri
15. Iatrogenic contribution to thoracic neoplasm Given continuing advances od early detection and supportive care and therapy : cancer survivor in USA is 3x since 1971 and increasing by 2% each year
Cancer survivor is about 3.5% of US population
We will meet second primary or late sequelae or treatment relate problem
Treatment-associated lung tumor: such as R/T and C/T
16. Lung cancer staging: intrathoracic nodal assessment 1982 a landmark paper by Dr pearson: mediastinal nodal metastasis could elude pre-op staging even in CT become routine and in which mediastinoscopy was well established
38% of case were upstaged at thoracotomy..Unexpect n2 disease
N2 has only 20% 5 years survival
Correct staging may improve survival
17. Radical or en block to describe nodal dissection technique.
1996 workshop: SND
Definition: number or node and at lease three mediastinal nodal station, and include one subcarina region
Review SND . Find 18% unexpect n2, no rescue
SND : better staging and find more ln deposit .
18. But early concern is add the morbility of surgery.
N0 survival was related to the number of node excised at thoracotomy
19. Definition of complete resection Lns specimens should include at lease six lymph node, three removed from intrapulmonary or hilar status and three removed from mediastinal station,one of which must be the subcarina station.
20. Other suggest: more extensive sectioning and immunohistochemical stain will find more subtle nodal deposit
21. PET CT 18-FDG
Phosphorylate
18-FDG-6-phosphate
Inside the tumor cell could not degrade and trapped in cell and accumulated
22. For SPN or lung mass 0.7cm -4cm can confirmed the maliganant
Sensitivity 92-94%
Specificity 86-90%
Duke : only 5% stage Ia is negative
23. False positive and negative False positive:TB or other grnulomatous disease; such as histoplasmosis coccidiomycosis or inflammatory process ;rheumatoid nodule, sarcoidosis or cryptogenic organizing pneumonia ,BOOP
False negative: carcinoid tumor BAC well differential adenocarcinoma or metastatic tumor from renal cell ca of testicular ca( most carcinoid are positive)
24. <1cm may not be detect
Limit is 7-8mm
Serum glucose result in decrease intracellular FDG uptake
At Mayo clinic do not perform PET scan unless blood glucose <150mg/dl
25. PET in staging or node or metas CT sensitivity 61% ,specificity 79%
PET 80% 90%
Due to false positive, if there are no documented distal metastasis , must be biopsy before patient be judge as unresectable
10-15% false positive , so if identified distal metas, esp one site metas, we would perform biopsy to get the potential curative thoracotomy
26. PET vs isotope bone scan Isotope bone scan have larger bone scan
If we already have PET scan , we have no reason obtaining a bone scan
But except brain . MRI or brain scan is better.